Vertex Pharmaceuticals Inc. (VRTX) News Headlines

▮ More

Date

Headline

1/11/2021 10:10:11 AM Vertex Pharmaceuticals To Present At The J.P. Morgan Healthcare Conference; Webcast At 9:10 AM ET

12/28/2020 8:33:18 AM Vertex's TRIKAFTA Accepted For Priority Review By Canada For Treatment Of Cystic Fibrosis

12/28/2020 8:08:34 AM Vertex Expects To Approve Cystic Fibrosis TRIKAFTA Medicine By Health Canada In H1 Of 2021

12/28/2020 8:03:29 AM Vertex : Canada Accepts New Drug Submission For Triple Combination Medicine For Treatment Of CF For Priority Review

12/22/2020 8:55:33 AM Skyhawk, Vertex Enter Into Research Collaboration On Serious Diseases

12/22/2020 8:34:20 AM Skyhawk Therapeutics, Vertex Announce Strategic Research Collaboration And Licensing Agreement

11/29/2020 8:12:00 PM Biotech Stocks Facing FDA Decision In December 2020

11/27/2020 3:19:59 AM Vertex: EU Approves SYMKEVI With KALYDECO For 6-11 Years Children With Cystic Fibrosis

11/27/2020 3:10:15 AM Vertex: European Commission Grant Approval Of Label Extension For SYMKEVI With KALYDECO For Cystic Fibrosis Age 6-11

11/13/2020 4:12:47 PM Vertex Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Investment Corp

11/5/2020 4:41:51 AM Vertex: European Commission Approves KALYDECO To Treat Infants With Cystic Fibrosis

11/5/2020 4:05:08 AM Vertex Pharma: European Commission Grants Approval Of Label Extension For KALYDECO Granules

11/5/2020 12:11:01 AM BIIB Faces FDA Panel Tomorrow, CRSP Climbs On Hemoglobinopathies Trial Data, SAVA On Watch

10/29/2020 5:17:02 PM Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates

10/29/2020 4:23:37 PM Vertex Pharma Q3 EPS $2.53 Vs. $0.22 Year Ago

10/29/2020 3:00:38 PM Vertex Pharmaceuticals Q3 20 Earnings Conference Call At 4:30 PM ET

10/15/2020 9:54:08 AM Stock Alert: Vertex Pharma Tanks 15% On Stopping Development Of Protein-deficiency Drug

10/15/2020 2:06:24 AM FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade

9/22/2020 9:15:39 AM CRISPR Therapeutics, Vertex Announce EMA Granted Priority Medicines Designation To CTX001

9/14/2020 5:42:06 AM Vertex Announces EMA Type II Variation Marketing Authorization Application Validation For KAFTRIO